Request Information

Auris Health Announces Results from Study of MONARCH® Platform at CHEST 2018 Late-Breaking Abstracts

Oct 08 2018

Auris News

Auris Health, Inc. announced the results of the Nodule Access study at the CHEST 2018 Annual Meeting in San Antonio. Alexander C. Chen, M.D., Director of Interventional Pulmonology at Washington University of St. Louis, shared the findings during the Late-Breaking Abstract session.

During the study, eight investigators performed robotic-assisted bronchoscopy procedure using the Monarch Platform on a cadaveric model designed to mimic a real-life bronchoscopy procedure. Sixty-seven simulated tumor targets 1-3cm in size, were prepared in eight human cadaveric lungs. The tissue acquired during the bronchoscopy was evaluated and correctly identified as the implanted target in 97% of cases.

“The ACCESS study showed that the Monarch Platform is able to successfully reach nodules in the lung in a cadaveric model and can successfully biopsy the tissue with a high accuracy,” said Dr. Chen. “This study was the next step following the REACH study, which focused on the Monarch Platform’s ability to reach deeper into the lung periphery.”

The REACH study, published earlier this year in the Annals of Thoracic Surgery, found that the platform improved reach beyond a conventional thin bronchoscope into the periphery of human cadaveric lungs.

“I’m excited about the potential of robotic bronchoscopy to allow us the opportunity to make the diagnosis of lung cancer earlier in its progression,” said Dr. Chen. “I look forward to assessing its performance in prospective human clinical trials in the near future.”

Auris Health, Inc. is a medical device company focusing on creating platforms that enhance physician capabilities, evolve minimally invasive techniques, and create new categories of care that redefine optimal patient outcomes.

Read full text
Back to all News